位置:首页 > 蛋白库 > ALGE2_AZOVI
ALGE2_AZOVI
ID   ALGE2_AZOVI             Reviewed;         997 AA.
AC   Q44495;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-MAY-2022, entry version 98.
DE   RecName: Full=Mannuronan C5-epimerase AlgE2 {ECO:0000305};
DE            EC=5.1.3.37 {ECO:0000269|PubMed:8188585};
DE   AltName: Full=Poly(beta-D-mannuronate) C5 epimerase 2;
GN   Name=algE2 {ECO:0000303|PubMed:7476166};
OS   Azotobacter vinelandii.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Azotobacter.
OX   NCBI_TaxID=354;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-15, FUNCTION, AND
RP   CATALYTIC ACTIVITY.
RC   STRAIN=E;
RX   PubMed=8188585; DOI=10.1128/jb.176.10.2846-2853.1994;
RA   Ertesvaag H., Doseth B., Larsen B., Skjaak-Braek G., Valla S.;
RT   "Cloning and expression of an Azotobacter vinelandii mannuronan C-5-
RT   epimerase gene.";
RL   J. Bacteriol. 176:2846-2853(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=E;
RX   PubMed=7476166; DOI=10.1111/j.1365-2958.1995.tb02433.x;
RA   Ertesvaag H., Hoeidal H.K., Hals I.K., Rian A., Doseth B., Valla S.;
RT   "A family of modular type mannuronan C-5-epimerase genes controls alginate
RT   structure in Azotobacter vinelandii.";
RL   Mol. Microbiol. 16:719-731(1995).
RN   [3]
RP   EXPRESSION.
RC   STRAIN=E;
RX   PubMed=11243259; DOI=10.1046/j.1462-2920.2000.00074.x;
RA   Hoeidal H.K., Glaerum Svanem B.I., Gimmestad M., Valla S.;
RT   "Mannuronan C-5 epimerases and cellular differentiation of Azotobacter
RT   vinelandii.";
RL   Environ. Microbiol. 2:27-38(2000).
RN   [4]
RP   REVIEW.
RX   PubMed=10937941; DOI=10.1006/mben.1999.0130;
RA   Ertesvaag H., Hoeidal H.K., Schjerven H., Glaerum Svanem B.I., Valla S.;
RT   "Mannuronan C-5-epimerases and their application for in vitro and in vivo
RT   design of new alginates useful in biotechnology.";
RL   Metab. Eng. 1:262-269(1999).
CC   -!- FUNCTION: Converts beta-D-mannuronic acid (M) to alpha-L-guluronic acid
CC       (G), producing a polymer with gel-forming capacity, required for the
CC       formation of the cyst coat. {ECO:0000269|PubMed:8188585}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[(1->4)-beta-D-mannuronosyl](n) = [alginate](n);
CC         Xref=Rhea:RHEA:45572, Rhea:RHEA-COMP:11264, Rhea:RHEA-COMP:11270,
CC         ChEBI:CHEBI:58187, ChEBI:CHEBI:85311; EC=5.1.3.37;
CC         Evidence={ECO:0000269|PubMed:8188585};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- ACTIVITY REGULATION: Inhibited by zinc.
CC   -!- PATHWAY: Glycan biosynthesis; alginate biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Secreted. Note=Probably exported via the
CC       hemolysin-type secretion pathway.
CC   -!- DEVELOPMENTAL STAGE: Produced mainly in encysting cells.
CC   -!- DOMAIN: Composed of one catalytically active A module and four R
CC       modules.
CC   -!- MISCELLANEOUS: Each enzyme of this family of C5 epimerases introduces
CC       its own characteristic sequence distribution of G-blocks in their
CC       substrates, explaining the extensive sequence variability of alginates.
CC       These alginates of varying composition have different physical
CC       properties and are necessary at different stages of the bacterium life
CC       cycle.
CC   -!- SIMILARITY: Belongs to the D-mannuronate C5-epimerase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L39096; AAA87312.1; -; Genomic_DNA.
DR   PIR; S77625; S77625.
DR   AlphaFoldDB; Q44495; -.
DR   SMR; Q44495; -.
DR   BRENDA; 5.1.3.37; 49.
DR   UniPathway; UPA00286; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0042121; P:alginic acid biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 2.150.10.10; -; 3.
DR   Gene3D; 2.160.20.10; -; 1.
DR   InterPro; IPR039448; Beta_helix.
DR   InterPro; IPR006633; Carb-bd_sugar_hydrolysis-dom.
DR   InterPro; IPR018511; Hemolysin-typ_Ca-bd_CS.
DR   InterPro; IPR001343; Hemolysn_Ca-bd.
DR   InterPro; IPR006626; PbH1.
DR   InterPro; IPR024535; Pectate_lyase_SF_prot.
DR   InterPro; IPR012334; Pectin_lyas_fold.
DR   InterPro; IPR011050; Pectin_lyase_fold/virulence.
DR   InterPro; IPR011049; Serralysin-like_metalloprot_C.
DR   Pfam; PF13229; Beta_helix; 1.
DR   Pfam; PF00353; HemolysinCabind; 4.
DR   Pfam; PF12708; Pectate_lyase_3; 1.
DR   SMART; SM00722; CASH; 2.
DR   SMART; SM00710; PbH1; 7.
DR   SUPFAM; SSF51120; SSF51120; 4.
DR   SUPFAM; SSF51126; SSF51126; 1.
DR   PROSITE; PS00330; HEMOLYSIN_CALCIUM; 6.
PE   1: Evidence at protein level;
KW   Alginate biosynthesis; Calcium; Direct protein sequencing; Isomerase;
KW   Repeat; Secreted.
FT   CHAIN           1..997
FT                   /note="Mannuronan C5-epimerase AlgE2"
FT                   /id="PRO_0000219556"
FT   REPEAT          133..155
FT                   /note="PbH1 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          157..179
FT                   /note="PbH1 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          180..202
FT                   /note="PbH1 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          204..226
FT                   /note="PbH1 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          257..279
FT                   /note="PbH1 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          280..315
FT                   /note="PbH1 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          320..359
FT                   /note="PbH1 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          388..403
FT                   /note="Hemolysin-type calcium-binding 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          406..422
FT                   /note="Hemolysin-type calcium-binding 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          424..439
FT                   /note="Hemolysin-type calcium-binding 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          557..573
FT                   /note="Hemolysin-type calcium-binding 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          574..591
FT                   /note="Hemolysin-type calcium-binding 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          696..711
FT                   /note="Hemolysin-type calcium-binding 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          713..730
FT                   /note="Hemolysin-type calcium-binding 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          828..839
FT                   /note="Hemolysin-type calcium-binding 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          846..862
FT                   /note="Hemolysin-type calcium-binding 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          864..880
FT                   /note="Hemolysin-type calcium-binding 10"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   997 AA;  103084 MW;  B3D3C1E57ADAC404 CRC64;
     MDYNVKDFGA LGDGVSDDTA AIQAAIDAAY AAGGGTVYLP AGEYRVSGGE EPSDGCLTIK
     SNVHIVGAGM GETVIKLVDG WDQDVTGIVR SAYGEETSNF GMSDLTLDGN RDNTSGKVDG
     WFNGYIPGED GADRDVTLER VEIREMSGYG FDPHEQTINL TIRDSVAHDN GLDGFVADFQ
     IGGVFENNVS YNNDRHGFNI VTSTNDFVLS NNVAYGNGGA GLVVQRGSSD VAHPYDILID
     GGAYYDNGLE GVQIKMAHDV TLQNAEIYGN GLYGVRVYGA EDVQILDNYI HDNSQNGSYA
     EILLQSYDDT AGVSGNFYTT TGTWIEGNTI VGSANSTYGI QERDDGTDYS SLYANSVSNV
     QNGSVRLYGA NSVVSDLPGT GQQATLEGTA GNDTLGGSDA HETLLGLDGN DRLNGGAGND
     ILDGGAGRDN LTGGAGADLF RVSARTDSYR TDSASFNDLI TDFDASQDRI DLSALGFTGL
     GDGYNGTLLL QVSADGSRTY LKSLEADAEG RRFEIALDGN FAGLLGAGNL LFERTAIEGD
     AGDNALLGTS AAETLLGHAG NDTLDGGAGD DILVGGAGRD SLTGGAGADV FRFDALSDSQ
     RNYDIGDNQG DRIADFAVGE DKLDVSALGF TGLGDGYNGT LALVLNSAGD RTYVKSYENG
     ADGYRFEFSL DGNYLELLGN EDFIFATPSG QQLLEGSAGN DSLQGTAADE VIHGGGGRDT
     LAGGAGADVF RFSELTDSYR DSASYADLIT DFDASEDRID LSGLGFSGLG NGYGGTLALQ
     VNSAGTRTYL KSFETNAAGE RFEIALDGDL SALGGANLIL DARTVLAGGD GNDTLSGSSA
     AEELLGGVGN DSLDGGAGND ILDGGAGRDT LSGGSGSDIF RFGGALDSFR NYASGTNGTD
     SITDFTPGED LIDLSVLGYT GLGDGYNGTL AIVLNDAGTK TYLKNRESDA EGNQFEIALE
     GNHADQLDAS DFIFATAAAT TGIEVVGGSG TQTDQLA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025